These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 57193)

  • 1. Seroepidemiological study of HBV infections in Athens, Greece.
    Papaevangelou G; Kyriakidou A; Vissoulis C; Trichopoulos D
    J Hyg (Lond); 1976 Apr; 76(2):229-34. PubMed ID: 57193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and epidemiologic significance of antibody to hepatitis B core antigen in Greece.
    Papaevangelou G; Karaboyia-Karafyllidis P; Kyriakidou A
    Am J Epidemiol; 1977 Dec; 106(6):502-6. PubMed ID: 930920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetic factors in thalassemia and hepatitis B infection. A multicentre study.
    Schanfield MS; Scalise G; Economidou I; Modell CB; Bate C; Zuckerman AJ
    Dev Biol Stand; 1975; 30():257-69. PubMed ID: 1204962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidemiologic study of hepatitis B virus in Bangkok, Thailand.
    Grossman RA; Benenson MW; Scott RM; Snitbhan R; Top FH; Pantuwatana S
    Am J Epidemiol; 1975 Feb; 101(2):144-59. PubMed ID: 1124753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.
    Alward WL; McMahon BJ; Hall DB; Heyward WL; Francis DP; Bender TR
    J Infect Dis; 1985 Apr; 151(4):604-9. PubMed ID: 2982971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A seroepidemiological study of the prevalence of hepatitis B infections in a hyperendemic New Zealand community.
    Milne A; Allwood GK; Moyes CD; Pearce NE; Newell K
    Int J Epidemiol; 1987 Mar; 16(1):84-90. PubMed ID: 3570626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation of infection with the hepatitis B agent to primary hepatic carcinoma.
    Blumberg BS; Larouzé B; London WT; Werner B; Hesser JE; Millman I; Saimot G; Payet M
    Am J Pathol; 1975 Dec; 81(3):669-82. PubMed ID: 174434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of hepatitis A and B in the Shanghai area: prevalence of serum markers.
    Hu MD; Schenzle D; Deinhardt F; Scheid R
    Am J Epidemiol; 1984 Sep; 120(3):404-13. PubMed ID: 6089547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigen e and its antibodies in acute serum hepatitis and in persons with a prolonged HBs-antigenemia].
    Paktoris EA; Trofimova LI; Sergeeva NA; Sinaĭko GA; Shakhgil'dian IV
    Vopr Virusol; 1979; (2):156-61. PubMed ID: 107654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of chronic HBsAg carriers in intrafamilial diffusion of hepatitis B virus infection].
    Pastore G; Dentico P; Angarano G; Pesce V; Schiraldi O
    Boll Ist Sieroter Milan; 1978 May; 57(2):197-203. PubMed ID: 728268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance.
    Trepo CG; Robert D; Motin J; Trepo D; Sepetjian M; Prince AM
    Gut; 1976 Jan; 17(1):10-13. PubMed ID: 1269974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological characteristics of the carriers with coexistence of HBsAg and anti-HBs based on a community cohort study.
    Pu Z; Li D; Wang A; Su H; Shao Z; Zhang J; Ji Z; Gao J; Choi BC; Yan Y
    J Viral Hepat; 2016 Apr; 23(4):286-93. PubMed ID: 26663578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiological study of hepatitis B virus markers in Japan.
    Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
    Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A sero-epidemiological study on HBV infection in a farm].
    Tan H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Dec; 11(6):334-7. PubMed ID: 2276181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic subgroups of hepatitis B (surface) antigen in Berlin (West) and their epidemiological aspects.
    Lange W; Overby LR; Werner J; Köhler H; Apodaca J
    Zentralbl Bakteriol Orig A; 1975 Sep; 233(1):1-7. PubMed ID: 53969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.
    Craxì A; Tinè F; Vinci M; Almasio P; Cammà C; Garofalo G; Pagliaro L
    Am J Epidemiol; 1991 Sep; 134(6):641-50. PubMed ID: 1951268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera.
    Chongsrisawat V; Thawornsuk N; Theamboonlers A; Louisirirotchanakul S; Poovorawan Y
    Viral Immunol; 2006; 19(4):623-9. PubMed ID: 17201657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.